Kevin C Tang's Net Worth
$40.3 Billion
Who is Kevin C Tang?
Kevin C Tang has an estimated net worth of $40.3 Billion. This is based on reported shares across multiple companies, which include Rain Oncology Inc., Odonate Therapeutics, Inc., Northstar Neuroscience, Inc., Mirati Therapeutics, Inc., Vanda Pharmaceuticals Inc., HERON THERAPEUTICS, INC. /DE/, Aptevo Therapeutics Inc., Cyclacel Pharmaceuticals, Inc., THRESHOLD PHARMACEUTICALS INC, LA JOLLA PHARMACEUTICAL CO, TCR2 THERAPEUTICS INC., Ardea Biosciences, Inc./DE, Jounce Therapeutics, Inc., TRIMERIS INC, QUESTCOR PHARMACEUTICALS INC, DEPOMED INC, ARADIGM CORP, NEOSE TECHNOLOGIES INC, TAPESTRY PHARMACEUTICALS, INC, PENWEST PHARMACEUTICALS CO, and ACLARA BIOSCIENCES INC.
SEC CIK
Kevin C Tang's CIK is 0001178579
Past Insider Trading and Trends
2018 was Kevin C Tang's most active year for acquiring shares with 106 total transactions. Kevin C Tang's most active month to acquire stocks was the month of August. 2021 was Kevin C Tang's most active year for disposing of shares, totalling 30 transactions. Kevin C Tang's most active month to dispose stocks was the month of October. 2017 saw Kevin C Tang paying a total of $70,045,907.28 for 4,171,136 shares, this is the most they've acquired in one year. In 2012 Kevin C Tang cashed out on 4,001,136 shares for a total of $125,743,763.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Rain Oncology Inc. (RAIN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.85M |
—
|
—
|
0
|
Jan 26
| |||
Form 4
| -4.32% | -173.97K |
$1.20 | -$209,412.98 | 3.85M |
Dec 14 - Dec 18
| |||
Form 4
| +7.60% | 284.14K |
$0.98 | $279,030.29 | 4.02M |
Oct 11 - Oct 13
| |||
Form 4
| +41.03% | 1.09M |
$1.06 | $1,158,763.96 | 3.74M |
May 30 - Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Odonate Therapeutics, Inc. (ODTC) Snapshot price: $3150
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.71% | -2.75M |
$2.09 | -$5,730,557.03 | 12.77M |
Nov 17 - Nov 19
| |||
Form 4
| +1.81% | 275.78K |
$15.16 | $4,181,207.92 | 15.51M |
Dec 21 - Dec 23
| |||
Form 4
| +0.73% | 110.88K |
$13.13 | $1,456,408.29 | 15.24M |
Sep 28 - Sep 29
| |||
Form 4
| +7.48% | 1.05M |
$14.25 | $14,999,991.75 | 15.13M |
Aug 28
| |||
Form 4
| +5.78% | 769.23K |
$26.00 | $20,000,006.00 | 14.08M |
Jun 26
| |||
Form 4
| +0.38% | 50K |
$26.15 | $1,307,545.60 | 13.31M |
Jun 14 - Jun 18
| |||
Form 4
| +0.58% | 76.31K |
$27.36 | $2,087,456.83 | 13.26M |
Jun 6 - Jun 7
| |||
Form 4
| +0.72% | 93.69K |
$24.92 | $2,335,216.80 | 13.18M |
Jun 3 - Jun 5
| |||
Form 4
| +1.08% | 140K |
$18.26 | $2,556,316.08 | 13.09M |
Mar 7 - Mar 8
| |||
Form 4
| +0.49% | 63.7K |
$13.11 | $835,106.86 | 12.95M |
Dec 27 - Dec 31
| |||
Form 4
| +0.47% | 60K |
$12.60 | $755,856.75 | 12.88M |
Dec 20 - Dec 26
| |||
Form 4
| +0.31% | 40K |
$14.67 | $586,638.90 | 12.82M |
Dec 14 - Dec 18
| |||
Form 4
| +0.16% | 20K |
$15.60 | $312,073.27 | 12.78M |
Dec 11 - Dec 12
| |||
Form 4
| +0.16% | 20K |
$14.79 | $295,863.90 | 12.76M |
Dec 6 - Dec 7
| |||
Form 4
| +0.02% | 3.06K |
$15.64 | $47,912.36 | 12.74M |
Nov 27
| |||
Form 4
| +0.13% | 16.94K |
$15.29 | $259,017.24 | 12.74M |
Nov 21 - Nov 26
| |||
Form 4
| +0.08% | 10K |
$14.87 | $148,727.00 | 12.72M |
Nov 1
| |||
Form 4
| +0.08% | 10.23K |
$14.98 | $153,366.75 | 12.71M |
Oct 26 - Oct 29
| |||
Form 4
| +0.31% | 39.77K |
$15.35 | $610,300.59 | 12.7M |
Oct 23 - Oct 25
| |||
Form 4
| +0.32% | 40K |
$19.16 | $766,307.58 | 12.66M |
Sep 27 - Sep 28
| |||
Form 4
| +0.32% | 40K |
$19.75 | $789,973.00 | 12.62M |
Sep 24 - Sep 26
| |||
Form 4
| +0.72% | 90K |
$19.55 | $1,759,295.75 | 12.58M |
Sep 18 - Sep 20
| |||
Form 4
| +0.06% | 7.5K |
$19.47 | $146,150.87 | 12.49M |
Aug 21
| |||
Form 4
| +0.40% | 49.69K |
$19.49 | $968,273.62 | 12.48M |
Aug 16 - Aug 20
| |||
Form 4
| +0.18% | 22.81K |
$18.93 | $431,704.67 | 12.44M |
Aug 13 - Aug 15
| |||
Form 4
| +0.11% | 14.05K |
$27.42 | $385,181.84 | 12.41M |
Feb 28 - Mar 1
| |||
Form 4
| +0.23% | 28.61K |
$27.42 | $784,638.03 | 12.4M |
Feb 23 - Feb 27
| |||
Form 4
| +0.32% | 39.08K |
$27.17 | $1,061,811.05 | 12.37M |
Feb 20 - Feb 22
| |||
Form 4
| +1.05% | 128.25K |
$22.47 | $2,881,343.79 | 12.33M |
Feb 14 - Feb 16
| |||
Form 4
| +11.84% | 1.29M |
$24.00 | $30,999,984.00 | 12.2M |
Dec 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Northstar Neuroscience, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.65% | 685K |
$1.08 | $736,837.50 | 3.46M |
Nov 18
| |||
Form 4
| +16.81% | 400K |
$1.25 | $499,920.00 | 2.78M |
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -4.76M |
—
|
—
|
0
|
Sep 15
| |||
Form 4
| +1.46% | 68.33K |
$1.79 | $122,582.80 | 4.76M |
May 12 - May 14
| |||
Form 4
| +3.46% | 156.68K |
$1.82 | $285,410.86 | 4.69M |
May 7 - May 9
| |||
Form 4
| +2.26% | 100K |
$1.83 | $183,000.00 | 4.53M |
May 2
| |||
Form 4
| +5.98% | 250K |
$1.81 | $452,360.00 | 4.43M |
Apr 29 - May 1
| |||
Form 4
| +9.99% | 380K |
$1.80 | $683,323.00 | 4.18M |
Apr 24 - Apr 28
| |||
Form 4
| +5.68% | 204.3K |
$1.79 | $365,974.88 | 3.8M |
Apr 16 - Apr 18
| |||
Form 4
| +7.51% | 251.44K |
$1.79 | $449,187.00 | 3.6M |
Apr 11 - Apr 15
| |||
Form 4
| +2.48% | 80.9K |
$1.82 | $146,834.00 | 3.35M |
Apr 8 - Apr 10
| |||
Form 4
| +9.01% | 270K |
$1.84 | $497,562.00 | 3.27M |
Apr 3 - Apr 7
| |||
Form 4
| +21.29% | 525.7K |
$1.71 | $898,332.84 | 3M |
Apr 2
| |||
Form 4
| +2.92% | 70K |
$1.67 | $117,194.00 | 2.47M |
Apr 1
| |||
Form 4
| +10.29% | 223.79K |
$1.56 | $349,941.60 | 2.4M |
Mar 27 - Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirati Therapeutics, Inc. (MRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.84% | 57.14K |
$17.50 | $1,000,002.50 | 1.24M |
Oct 24
| |||
Form 4
| -3.03% | -36.90K |
$16.34 | -$602,847.44 | 1.18M |
Sep 19 - Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $3.635
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.98% | -54.90K |
$10.73 | -$589,181.31 | 2.72M |
Jan 14
| |||
Form 4
| -5.12% | -149.60K |
$10.72 | -$1,603,016.00 | 2.77M |
Jan 11 - Jan 13
| |||
Form 4
| -4.75% | -145.50K |
$11.60 | -$1,687,582.65 | 2.92M |
Jan 4 - Jan 5
| |||
Form 4
| -16.37% | -600.00K |
$12.67 | -$7,602,626.50 | 3.07M |
Oct 13 - Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26 - May 28
| |||
Form 4
| +4.12% | 145K |
$0.73 | $105,531.00 | 3.67M |
Nov 20
| |||
Form 4
| +18.91% | 560K |
$0.83 | $464,296.00 | 3.52M |
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -70.73% | -2.66M |
—
|
—
| 1.1M |
Sep 15
| |||
Form 4
| +11.95% | 600K |
$1.04 | $622,680.00 | 5.62M |
Sep 25
| |||
Form 4
| +1.62% | 80K |
$0.98 | $78,520.00 | 5.02M |
Sep 23
| |||
Form 4
| +2.07% | 100K |
$1.00 | $99,880.00 | 4.94M |
Sep 22
| |||
Form 4
| +28.76% | 1.08M |
$0.98 | $1,058,478.36 | 4.84M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||